Sign in

Filings

Finds words inside filing documents. Searching Cocrystal Pharma, Inc.'s filings · 62 documents indexed.

19 documents · 27 matches

  1. COCP Cocrystal Pharma, Inc. 10-K 2026-03-31

    Item 1A. Risk Factors

    tariffs by the U.S. and any retaliatory actions by foreign countries, as well as refunds on tariffs following the U.S. Supreme
    7 matches in this document

  2. COCP Cocrystal Pharma, Inc. 8-K 2026-09-09

    tariffs and developments with respect thereto, and wars and geopolitical conflicts including those in Ukraine and with Iran on our Company
    1 match in this document

  3. COCP Cocrystal Pharma, Inc. 10-Q 2026-08-13

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff policy, which could have a material effect on increasing the Company’s operating costs, and which would put additional
    1 match in this document

  4. COCP Cocrystal Pharma, Inc. 8-K 2026-08-03

    tariffs and developments with respect thereto, and wars and geopolitical conflicts including those in Ukraine and with Iran on our Company
    1 match in this document

  5. COCP Cocrystal Pharma, Inc. 8-K 2026-06-03

    tariffs and developments with respect thereto, and wars and geopolitical conflicts including those in Ukraine and with Iran on our Company
    1 match in this document

  6. COCP Cocrystal Pharma, Inc. 8-K 2026-05-26

    tariffs and developments with respect thereto, and wars and geopolitical conflicts including those in Ukraine and with Iran on our Company
    1 match in this document

  7. COCP Cocrystal Pharma, Inc. 10-Q 2026-05-15

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff policy, which could have a material effect on increasing the Company’s operating costs, and which would put additional
    2 matches in this document

  8. COCP Cocrystal Pharma, Inc. 8-K 2026-03-31

    tariffs and developments with respect thereto, and wars and geopolitical conflicts including those in the Middle East and Ukraine on our Company
    1 match in this document

  9. COCP Cocrystal Pharma, Inc. 8-K 2026-03-09

    tariffs and litigation and developments relating thereto, and geopolitical conflicts including those in the Middle East and Ukraine on our Company
    1 match in this document

  10. COCP Cocrystal Pharma, Inc. 8-K 2026-02-19

    tariffs and the resulting litigation, and geopolitical conflicts including those in Ukraine, Latin America and Middle East on our Company
    1 match in this document

  11. COCP Cocrystal Pharma, Inc. 8-K 2025-12-18

    tariffs and the resulting litigation, and geopolitical conflicts including those in Ukraine and Middle East on our Company, our collaboration
    1 match in this document

  12. COCP Cocrystal Pharma, Inc. 8-K 2025-11-14

    tariffs, and geopolitical conflicts including those in Ukraine and Israel on our Company, our collaboration partners, and on the U.S., UK, Australia
    1 match in this document

  13. COCP Cocrystal Pharma, Inc. 10-Q 2025-08-14

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff policy, which could have a material effect on increasing the Company’s operating costs, and which would put additional
    1 match in this document

  14. COCP Cocrystal Pharma, Inc. 8-K 2025-08-14

    tariffs, and geopolitical conflicts including those in Ukraine and Israel on our Company, our collaboration partners, and on the U.S., UK, Australia
    1 match in this document

  15. COCP Cocrystal Pharma, Inc. 8-K 2025-08-05

    tariffs which may cause delays or force us to incur additional costs to proceed without development programs. Further information on our risk
    1 match in this document

  16. COCP Cocrystal Pharma, Inc. 8-K 2025-07-10

    tariffs which may cause delays or force us to incur additional costs to proceed without development programs. Further information on our risk
    1 match in this document

  17. COCP Cocrystal Pharma, Inc. 8-K 2025-06-05

    tariffs which may cause delays or force us to incur additional costs to proceed without development programs. Further information on our risk
    1 match in this document

  18. COCP Cocrystal Pharma, Inc. 10-Q 2025-05-15

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff policy, which could have a material effect on increasing the Company’s operating costs, and which would put additional
    2 matches in this document

  19. COCP Cocrystal Pharma, Inc. 8-K 2025-05-15

    tariffs, and geopolitical conflicts including those in Ukraine and Israel on our Company, our collaboration partners, and on the U.S., UK, Australia
    1 match in this document

Page 1 of 1 · 19 documents